Investor Relations

Orexo's share is listed on NasdaqOMX Stockholm, Sweden (ORX), and is available as American Depository Receipts on OTCQX market in the US (OXROY).

Share price

Name
0.00
0 SEK (0%)
HH:MM CET • 20YY-MM-DD

Latest CEO Comments

NOVEMBER 4, 2020

"Keeping focus and maximizing business opportunities in a challenging environment"

Read the latest CEO comments from Nikolaj Sørensen

Key financial figures

Group net revenue

742 MSEK
Last Twelve Months, Q419-Q320

Group EBITDA

104 MSEK
Last Twelve Months, Q419-Q320

US Pharma segment EBIT

331 MSEK
Last Twelve Months, Q419-Q320

Cash position

593 MSEK
Q320
IR-Contact